ABCL
AbCellera Biologics Inc.D4515-min delayed · EOD close12.27 −6.19% downas of 2026-10-30mkt cap $3.8B
Pharmaceutical Preparations · SIC 2834 · CIK 0001703057
Quality score
45/100
D
Growth63
Business quality0
missing: grossMargin
Financial health80
Valuation39
missing: peRatio
Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.
The read
Mixed picture
Highly uneven
Strongest on financial health (80), weakest on business quality (0). The composite is the mean of the sub-scores that could be computed. 2 inputs were unavailable in the filings, so the score reflects what was reported.
Revenue growth
129.5%
year over year
Earnings growth
-1.1%
year over year